IFPA

Global leader in fighting psoriatic disease

Vision

A future where all people living with psoriatic disease enjoy good health and wellbeing, free from stigma and preventable disability and comorbidities

Mission

Unite, strengthen and lead the global psoriatic disease community to improve the lives of all people affected by psoriatic disease.

02/09/2026

Clinical trials drive medical progress and shape the future of healthcare. But how much do we really know about how they work?

Who can take part and what does joining a clinical trial actually involve? How do we make sure clinical research represents the diversity of people living with psoriasis and psoriatic arthritis?

These are some of the questions we’ll unpack in our new webinar: Clinical Trials Demystified: Everything You Wanted to Know About Clinical Trials (But Were Afraid to Ask) — the first webinar in our Towards Inclusive and Equitable Clinical Trials series.

Our speakers:
🎙️ Professor Mahira El Sayed, Professor of Dermatology and Venereology and Board Member of the International Psoriasis Council (IPC)
🎙️ Dr. Frida Lundmark, Director Science Policy at LIF — the Swedish Association of the Pharmaceutical Industry
🎙️ Keith Berelowitz, Founder and CEO of Trialport

📅 18 September
⏰ 10:00–11:00 CET

The webinar is part of Breaking Barriers, IFPA’s global initiative to promote more inclusive and equitable clinical trials for people living with psoriatic disease.

Whether you live with psoriatic disease, represent a patient organization, work in healthcare or research, or simply want to understand clinical trials better — join the conversation.

🔗 Register now to secure your spot:
https://eu1.hubs.ly/H0y0m1d0

01/09/2026

🌍 It’s the Global Week for Action on NCDs, taking place from 31 August to 4 September.

Under this year’s theme, it is our chance to come together and call for stronger action to prevent and treat noncommunicable diseases (NCDs).

NCDs remain the world’s leading cause of death and disability. By 2030, annual deaths from NCDs could rise to 52 million if we fail to act. At the same time, many NCDs still do not receive the attention they deserve on the global health agenda.

Psoriasis and psoriatic arthritis, often referred to as psoriatic disease, are among them. Together, they affect more than 100 million people worldwide and are linked to other serious NCDs, including cardiovascular disease, diabetes, depression and anxiety.

In a recent blog for the NCD Alliance, our Executive Director Frida Dunger highlights new research showing that investing in earlier and more effective treatment of psoriasis and psoriatic arthritis could save billions for health systems and economies.

Let's together.

👉 Read the article here: https://eu1.hubs.ly/H0x-pMm0

27/08/2026

Registration for the 8th World Psoriasis & Psoriatic Arthritis Conference opens on 1 September 2026.

If you work in dermatology, rheumatology or related fields, this conference is a must.

The 8th World Psoriasis & Psoriatic Arthritis Conference is the world's only global multidisciplinary scientific congress dedicated entirely to psoriasis and psoriatic arthritis, bringing together leading researchers, healthcare professionals, patient experts and advocates from around the world.

📍 Stockholm Waterfront Congress Centre, Sweden
📅 20–22 May 2027

Key dates:
🗓️ Registration opens: 1 September 2026
📄 Abstract submission opens: 1 October 2026

Be part of the conversations shaping the future of psoriatic disease research and care.

Read more: https://eu1.hubs.ly/H0xTRZ60

26/08/2026

It’s

What does a day at work really look like when you live with psoriatic arthritis?

For Shrestha, a content producer from India living with psoriasis and psoriatic arthritis, it's not just the hours spent filming that take a toll.

What many people don't see is how much time chronic disease takes away, not just from work, but from life. Time spent recovering instead of living.

In her mini-documentary, Shrestha shares the hidden mental, emotional and physical impact of living with psoriatic disease.

🎥 Watch the full video: https://eu1.hubs.ly/H0xSy-00

21/08/2026

We don’t talk enough about how living chronic conditions affect your social life.

"I worry they'll stop asking me."
Living with psoriatic arthritis often means spending the evening recovering while everyone else is making plans.

That's the reality for Shrestha. After a day of pushing through pain and fatigue, she often has just enough energy to make it home. That's usually when her friends are heading out.

In her mini-documentary, Shrestha, 25, shares what living with psoriasis and psoriatic arthritis really feels like.

🎥 Watch her story: https://eu1.hubs.ly/H0xMM9d0

18/08/2026

What can we gain by preventing the serious conditions linked to psoriasis and psoriatic arthritis?
Far more than we realize.

We are happy to share our newly published blog for the NCD Alliance, where IFPA Executive Director Frida Dunger explains why investing in prevention, early diagnosis and effective treatment is one of the smartest choices we can make – for people, for health systems and for economies.

🔗 Read the blog:
https://eu1.hubs.ly/H0xJxnj0

17/08/2026

How do you show up at work, with friends, and in everyday life when you're living with a serious chronic condition like psoriatic arthritis?

"The thought of getting out of bed is painful. My joints feel stiff, and it takes nearly an hour for my body to ease into the day," confesses Shrestha, 25, a content creator from India living with plaque psoriasis and psoriatic arthritis.

Watch her mini-documentary as she opens up about navigating life, overcoming daily challenges and refusing to let her diagnosis define her.
🎥 https://eu1.hubs.ly/H0xGTxR0

13/08/2026

August 13 is GPP Awareness Day.

Generalized Pustular Psoriasis (GPP) is a rare, severe, and potentially life-threatening form of psoriasis. Globally, it affects an estimated 1–9 people per million.

It is more common in women and often appears in midlife.
Living with a rare disease like GPP can be an overwhelming and isolating experience.

Our ambassador, Kate Reynolds, is one of the advocates working to raise awareness of the disease.

Kate, known as The Lavender Librarian, is a children's librarian from Ontario, Canada. Her first outbreak of GPP was nearly fatal and it dramatically changed her life.

When she tried to explain her diagnosis to her employer, she faced another challenge: a lack of knowledge about the disease and how it affects a person's health and ability to work.

To make a difference, Kate joined IFPA (International Federation of Psoriasis Associations) to help more people understand GPP and other forms of psoriatic disease and advocate for better health for everyone living with these conditions.

➡️ Targeted research and early diagnosis are crucial.
🔗 Learn more: https://eu1.hubs.ly/H0xCP0x0

10/08/2026

It's Psoriasis Awareness Month. 💜

People living with psoriasis and psoriatic arthritis deserve to be seen, heard, and taken seriously.

If someone you know is living with these conditions, show them your understanding and support.

If it's you, take a moment to acknowledge your strength and give yourself a hug. 💜

Let's raise awareness, break stigma, and drive action for better care and better lives.

No one should have to face these diseases alone.

06/08/2026

Are you engaged in research on psoriasis, psoriatic arthritis, and related fields?

We are thrilled to announce that the abstract submission guidelines for IFPA Conference 2027 are now available!

Get ready for IFPA Conference — the 8th World Psoriasis & Psoriatic Arthritis Conference — the only global scientific event dedicated to cutting-edge research and innovation in psoriasis, psoriatic arthritis, and related fields.

📅 May 20–22, 2027
📍 Waterfront Congress Centre, Stockholm, Sweden

Every three years since 2006, we bring together world-leading experts in dermatology, rheumatology, and beyond to engage with the critical issues affecting people living with psoriatic disease.

The full abstract submission guidelines for the conference are now available on the conference website.

📅 Key dates:
🔸 Conference registration open — September 1, 2026
🔸 Abstract submission opens: October 1, 2026 (via the conference website)
🔸 Submission deadline: 15 November 2026, 16:00 CET

👉 Check the full guidelines on the conference website: https://eu1.hubs.ly/H0xtVJt0

Adress

Slottsbacken 8
Stockholm
SE-16751

Webbplats

http://www.ifpa-pso.com/

Aviseringar

Var den första att veta och låt oss skicka ett mail när IFPA postar nyheter och kampanjer. Din e-postadress kommer inte att användas för något annat ändamål, och du kan när som helst avbryta prenumerationen.

Vill du placera din organisation längst upp i Ideell Organisation-listan i Stockholm?